[Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].

Google Scholar
  • 28 April 1976
    • journal article
    • research article
    • Vol. 28  (15) , 911-21
Abstract
No abstract available